OncoZenge AB (publ) (STO:ONCOZ)

OncoZenge AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.86	12.63	29.14	51.22	10
Cash & Short-Term Investments	3.86	12.63	29.14	51.22	10
Cash Growth	-69.41%	-56.67%	-43.11%	412.23%	-
Other Receivables	0.52	0.64	0.71	0.85	5.51
Receivables	0.52	0.64	0.71	0.85	5.51
Prepaid Expenses	0.2	0.2	0.19	0.06	-
Other Current Assets	-	0.02	-	-	-
Total Current Assets	4.58	13.49	30.04	52.13	15.51
Other Intangible Assets	6.85	6.85	6.85	6.85	22.05
Long-Term Deferred Tax Assets	-	-	-	3.08	0.73
Long-Term Deferred Charges	-	-	-	23.17	-
Total Assets	11.43	20.34	36.89	85.23	38.3
Accounts Payable	0.66	0.93	1.65	4.02	-
Accrued Expenses	0.78	0.66	1.01	0.5	2.8
Other Current Liabilities	0.05	0.11	0.26	0.39	6.21
Total Current Liabilities	1.48	1.7	2.92	4.9	9.01
Total Liabilities	1.48	1.7	2.92	4.9	9.01
Common Stock	1.3	1.3	1.3	1.3	0.5
Additional Paid-In Capital	84.41	84.41	83.84	83.54	29.32
Retained Earnings	-75.76	-67.07	-51.17	-4.52	-0.64
Comprehensive Income & Other	-	-	-	-	0.1
Shareholders' Equity	9.95	18.64	33.97	80.32	29.28
Total Liabilities & Equity	11.43	20.34	36.89	85.23	38.3
Net Cash (Debt)	3.86	12.63	29.14	51.22	10
Net Cash Growth	-69.41%	-56.67%	-43.11%	412.23%	-
Net Cash Per Share	0.33	1.08	2.49	4.35	-
Filing Date Shares Outstanding	11.71	11.71	11.71	11.71	-
Total Common Shares Outstanding	11.71	11.71	11.71	11.71	-
Working Capital	3.1	11.79	27.12	47.23	6.5
Book Value Per Share	0.85	1.59	2.90	6.86	-
Tangible Book Value	3.1	11.79	27.12	73.47	7.23
Tangible Book Value Per Share	0.26	1.01	2.32	6.27	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.